Advertisement
UK markets open in 39 minutes
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,715.29
    +430.75 (+2.49%)
     
  • CRUDE OIL

    84.01
    +0.44 (+0.53%)
     
  • GOLD FUTURES

    2,350.50
    +8.00 (+0.34%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • Bitcoin GBP

    51,524.79
    +151.78 (+0.30%)
     
  • CMC Crypto 200

    1,392.75
    -3.79 (-0.27%)
     
  • NASDAQ Composite

    15,611.76
    -100.99 (-0.64%)
     
  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     

Creating and Protecting IP Value in Connection with VC Financings

How do venture capital investors value formal Intellectual Property (IP) rights in connection with a decision to fund a technology or life sciences start-up? How do they conduct IP due diligence? How do investors and founders, post-funding, ensure their start-ups are pursuing an IP strategy that optimizes exit valuation for all? Perkins Coie partners Michael Glenn (Patent Prosecution) and Matt Oshinsky (Emerging Companies Venture Capital) will be joined alongside a seasoned venture capitalist to discuss these and other questions regarding safeguarding IP rights and maximizing the value of all technology development activities.